These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 856462)

  • 61. Distribution of adriamycin in cancer patients: tissue uptakes, plasma concentration after IV and hepatic IA administration.
    Lee YT; Chan KK; Harris PA; Cohen JL
    Cancer; 1980 May; 45(9):2231-9. PubMed ID: 7379023
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A pharmacokinetic study of adriamycin and 4'epi-adriamycin after simultaneous intra-arterial liver administration.
    Eksborg S; Andersson M; Domellöf L; Lönroth U
    Med Oncol Tumor Pharmacother; 1986; 3(2):105-10. PubMed ID: 3462442
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Simplified toxicologic monitoring of adriamycin, its major metabolites and nogalamycin by reverse-phase high pressure liquid chromatography, Part I: Analytical techniques for isolated human plasma.
    Quattrone AJ; Ranney DF
    J Anal Toxicol; 1980; 4(1):12-5. PubMed ID: 6927044
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effects of cimetidine upon the plasma pharmacokinetics of doxorubicin in rabbits.
    Brenner DE; Collins JC; Hande KR
    Cancer Chemother Pharmacol; 1986; 18(3):219-22. PubMed ID: 3802377
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adriamycin uptake and metabolism in organotypic culture of A549 human adenocarcinoma cells according to the exposure time.
    Chevillard S; Vielh P; Bastian G; Coppey J
    J Cancer Res Clin Oncol; 1990; 116(6):633-8. PubMed ID: 2254382
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography.
    Bolanowska W; Gessner T; Preisler H
    Cancer Chemother Pharmacol; 1983; 10(3):187-91. PubMed ID: 6574828
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intrahepatic and intravenous administration of adriamycin--a comparative pharmacokinetic study in patients with malignant liver tumours.
    Eksborg S; Cedermark BJ; Strandler HS
    Med Oncol Tumor Pharmacother; 1985; 2(1):47-54. PubMed ID: 4058077
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Analysis of doxorubicin, 4'-epidoxorubicin, and their metabolites by liquid chromatography.
    Weenen H; Osterop AP; van der Poort SE; Lankelma J; van der Vijgh WJ; Pinedo HM
    J Pharm Sci; 1986 Dec; 75(12):1201-4. PubMed ID: 3470504
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacokinetics of adriamycin in patients with breast cancer: correlation between pharmacokinetic parameters and clinical short-term response.
    Robert J; Illiadis A; Hoerni B; Cano JP; Durand M; Lagarde C
    Eur J Cancer Clin Oncol; 1982 Aug; 18(8):739-45. PubMed ID: 6891324
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of whole-body hyperthermia on the disposition and metabolism of adriamycin in rabbits.
    Mimnaugh EG; Waring RW; Sikic BI; Magin RL; Drew R; Litterst CL; Gram TE; Guarino AM
    Cancer Res; 1978 May; 38(5):1420-5. PubMed ID: 639069
    [No Abstract]   [Full Text] [Related]  

  • 71. Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma (ROS).
    Cummings J; Merry S; Willmott N
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):451-60. PubMed ID: 3460809
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacokinetics and metabolism of adriamycin in man.
    Benjamin RS; Riggs CE; Bachur NR
    Clin Pharmacol Ther; 1973; 14(4):592-600. PubMed ID: 4723268
    [No Abstract]   [Full Text] [Related]  

  • 73. Analysis of adriamycin and adriamycinol in micro volumes of rat plasma.
    Bots AM; Van Oort WJ; Noordhoek J; Van Dijk A; Klein SW; Van Hoesel QG
    J Chromatogr; 1983 Feb; 272(2):421-7. PubMed ID: 6833441
    [No Abstract]   [Full Text] [Related]  

  • 74. Plasma pharmacokinetics of adriamycin after intrapleural administration.
    Eksborg S; Lindfors A; Cedermark BJ
    Med Oncol Tumor Pharmacother; 1984; 1(3):193-4. PubMed ID: 6544898
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pharmacokinetics of adriamycin (NSC-123127) in patients with sarcomas.
    Benjamin RS
    Cancer Chemother Rep; 1974; 58(2):271-3. PubMed ID: 4830501
    [No Abstract]   [Full Text] [Related]  

  • 76. Protein binding of anthraquinone glycosides, with special reference to adriamycin.
    Eksborg S; Ehrsson H; Ekqvist B
    Cancer Chemother Pharmacol; 1982 Dec; 10(1):7-10. PubMed ID: 7160048
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Quantitative thin-layer chromatography: thin-film fluorescence scanning analysis of adriamycin and metabolites in tissue.
    Chan KK; Wong CD
    J Chromatogr; 1979 Apr; 172():343-9. PubMed ID: 548536
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Quantitative thin-layer chromatographic measurement of n-trifluoroacetyladriamycin-14-valerate (AD 32) and trifluoroacetyladriamycin (AD 41) in blood and tissues.
    Barbieri B; Abbruzzi R; Benigni A; Rizzardini M; Donelli MG; Garattini S; Salmona M
    J Chromatogr; 1979 Jun; 163(2):195-200. PubMed ID: 541371
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A comparison of the pharmacokinetics of multiple and single dose administrations of adriamycin.
    Siemann DW; Sutherland RM
    Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1271-4. PubMed ID: 528276
    [No Abstract]   [Full Text] [Related]  

  • 80. Isotachophoretic determination of adriamycin and adriamycinol in human plasma.
    Akedo H; Shinkai K
    J Chromatogr; 1982 Jan; 227(1):262-5. PubMed ID: 7056819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.